ARTICLE | Company News
AnalytiCon, Merck KGaA deal
June 4, 2007 7:00 AM UTC
AnalytiCon will use its MEGAbolite technology to identify, isolate, purify and characterize natural products from plant and microbial extracts to treat undisclosed diseases for MRK, which will perform...